Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Figure E - Secondary Antimicrobial Drug Used to Treat Gonorrhea among GISP Participants

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 

 

CLINIC Percentage
Doxy/Tet Azi/Ery None/Other
ALBUQUERQUE 0.9 98.2 0.9
ATLANTA . 97.3 2.7
BIRMINGHAM 29.7 61.6 8.7
BOSTON . 92.3 7.7
BUFFALO 1.2 97.6 1.2
CHICAGO 0.8 97.6 1.6
CLEVELAND 3.5 91.2 5.3
COLUMBUS 3.1 91.5 5.4
DALLAS 0.7 99.3 .
GREENSBORO . 100.0 .
HONOLULU . 99.2 0.8
INDIANAPOLIS . 95.7 4.3
KANSAS CITY . 99.1 0.9
LAS VEGAS . 100.0 .
LOS ANGELES 1.2 93.6 5.3
MINNEAPOLIS 1.0 96.1 2.9
NEW ORLEANS . 54.4 45.6
NEW YORK CITY 3.0 90.2 6.8
ORANGE COUNTY 1.2 94.7 4.1
PHILADELPHIA 0.7 99.3 .
PHOENIX 0.3 99.3 0.3
PONTIAC 6.1 93.2 0.8
PORTLAND 0.8 75.0 24.2
SAN DIEGO . 91.7 8.3
SAN FRANCISCO 1.0 90.7 8.3
SEATTLE 0.5 77.3 22.2
TRIPLER 10.0 90.0 .
TOP